CRL Financial Facts
Cost of products sold: 69.33MNet sales related to services: 292.85M
See Full Income Statement
See Full Balance Sheet
Charles River Laboratories International, Inc. (CRL) Earnings
|
Expand Research on CRL
Next EPS Date | 5/1/24 | EPS Growth Rate | -24.5% |
---|---|---|---|
Average EPS % Beat Rate | +6.6% | Revenue Growth Rate | -3.4% |
Average % Move 1-Wk after EPS | +3.4% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/1/24 | Q124 | N/A | $2.10 | N/A | N/A | $994.65M | N/A | N/A | |||
2/14/24 | Q423 | $2.46 | $2.41 | +$0.05 | $1.01B | $991.25M | Details | ||||
11/8/23 | Q323 | $2.72 | $2.36 | +$0.36 | $1.03B | $1B | = | Details | |||
8/9/23 | Q223 | $2.69 | $2.64 | +$0.05 | $1.06B | $1.05B | = | Details | |||
5/11/23 | Q123 | $2.78 | $2.59 | +$0.19 | $1.03B | $986.31M | = | Details | |||
2/22/23 | Q422 | $2.98 | $2.75 | +$0.23 | $1.1B | $1.04B | = | Details | |||
11/2/22 | Q322 | $2.63 | $2.54 | +$0.09 | $989.2M | $974.65M | = | Details | |||
8/3/22 | Q222 | $2.77 | $2.75 | +$0.02 | $973.1M | $997.96M | = | Details |